ID   39-10
AC   CVCL_C6NF
SY   5F2 TK10P2; 5F2
DR   Wikidata; Q116048135
RX   Patent=US9139655;
RX   Patent=US9540447;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-08628.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9ULW2; Human FZD10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
RX   Patent=US9139655;
RA   Nakamura Y., Katagiri T., Nakatsuru S., Endo K., Kuhara M., Yagi K.;
RT   "Tumor-targeting monoclonal antibodies to FZD10 and uses thereof.";
RL   Patent number US9139655, 22-Sep-2015.
//
RX   Patent=US9540447;
RA   Nakamura Y., Katagiri T., Fukukawa C., Kuhara M.;
RT   "Method for treating synovial sarcoma.";
RL   Patent number US9540447, 10-Jan-2017.
//